Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes

Forleo, Giovanni B.; Tesauro, Manfredi; Panattoni, Germana; Rocca, Domenico G. Della; Papavasileiou, Lida P.; Sergi, Domenico; Molfetta, Arianna Di; Santini, Luca; Romeo, Francesco

doi:10.1136/heartjnl-2011-300801

Cited by 22 publications

(13 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The investigators suggested that continuous measurements of TWA/V from the intracardiac ICD electrograms may be a useful parameter to detect impending VT/VF and allow the device to initiate pacing therapies to prevent the ventricular arrhythmias from occurring. In contrast, an early analysis of a prospective, single centre study on the use of ICD based ischaemia monitoring on clinical care and patient management reported that this parameter was not clinically useful and actually increased the number of unscheduled outpatient visits in patients with this feature on their ICD compared with patients with ICDs without this capability [118].…”

Section: Implantable Cardioverter Defibrillatorsmentioning

confidence: 94%

Almanac 2013: cardiac arrhythmias and pacing

Liew¹

2013

Seminars in Cardiovascular Medicine

View full text Add to dashboard Cite

Summary Important advances have been made in the past few years in the fields of clinical cardiac electrophysiology and pacing. Researchers and clinicians have a greater understanding of the pathophysiological mechanisms underlying atrial fibrillation (AF), which has transpired into improved methods of detection, risk stratification, and treatments. The introduction of novel oral anticoagulants has provided clinicians with alternative options in managing patients with AF at moderate to high thromboembolic risk and further data has been emerging on the use of catheter ablation for the treatment of symptomatic AF. Another area of intense research in the field of cardiac arrhythmias and pacing is in the use of cardiac resynchronisation therapy (CRT) for the treatment of patients with heart failure. Following the publication of major landmark randomised controlled trials reporting that CRT confers a survival advantage in patients with severe heart failure and improves symptoms, many subsequent studies have been performed to further refine the selection of patients for CRT and determine the clinical characteristics associated with a favourable response. The field of sudden cardiac death and implantable cardioverter defibrillators also continues to be actively researched, with important new epidemiological and clinical data emerging on improved methods for patient selection, risk stratification, and management. This review covers the major recent advances in these areas related to cardiac arrhythmias and pacing.

show abstract

Section: Implantable Cardioverter Defibrillatorsmentioning

confidence: 94%

Almanac 2013: cardiac arrhythmias and pacing

Liew¹

2013

Seminars in Cardiovascular Medicine

View full text Add to dashboard Cite

show abstract

“…If an ST shift is detected, the device will store the episode date and time of onset, the heart rate, the duration, and the maximum ST shift registered. Each stored ST-shift episode has three more electrograms: the baseline IEGM obtained in the previous 72 h, an IEGM taken at the time of detection of the event (time of onset), and an IEGM that records the largest measured ST-shift during the episode [66]. Integration of ST monitoring algorithms with remote monitoring systems might anticipate ischemic events and therefore prevent major complications [67].…”

Section: Continuous Intracardiac St-segment Monitoringmentioning

confidence: 99%

Novel devices to monitor heart failure and minimize hospitalizations

Papavasileiou

Santini

Forleo

et al. 2016

Expert Review of Cardiovascular Therapy

Self Cite

View full text Add to dashboard Cite

This review aims to cover both implantable and non-implantable devices available for monitoring various hemodynamic parameters and clinical features of patients, as well as algorithms implemented in the new generation ICDs and CRTs capable of simultaneous acquisition and transmission of multiple parameters that indirectly evaluate clinical and/or hemodynamic status. Both internet and PubMed searches were used in order to acquire the most recent developments in the technology of the field. Expert commentary: As new technology offers an enormous data flow, the key for success in the battle against heart failure and related hospitalizations is understanding the correct way of utilizing the data acquired and their importance for the treatment of each individual person.

show abstract

“…Follow-up and heart failure events According to the protocol used in our institution, 19 clinical evaluation and device testing were carried out at each follow-up evaluation scheduled at 1 and 3 months after CRT implantation and every 6 months thereafter, except for acute events. For the purpose of this article, we identified individualswith at least 90 days of impedance monitoring stored in the device.…”

Section: Patients and Study Protocolmentioning

confidence: 99%